systemic%20lupus%20erythematosus
SYSTEMIC LUPUS ERYTHEMATOSUS
Systemic lupus erythematosus is a chronic, multisystem, inflammatory, autoimmune disorder characterized by formation of autoantibodies directed against self-antigens and immune-complex formation.
It can be diagnosed with a single organ involvement such as lupus nephritis.
It is predominantly diagnosed in females of childbearing age.
Clinical presentation varies in different patients and the disease activity varies over time in a single patient. Majority of patients have arthralgia of the hand.

Systemic Lupus Erythematosus Drug Information

Drug Information

Indication: Eczema including atopic, infantile, discoid & stasis eczema; prurigo; psoriasis; neurodermatoses including...

Indication: Short-term treatment of corticosteroid-responsive resistant dermatoses eg, psoriasis, recalcitrant eczema, lic...

Indication: Symptomatic treatment of allergic dermatoses & other forms of contact dermatitis, insect bites; atopic, ec...

Indication: Reducing disease activity in adult patients w/ active autoantibody +ve SLE receiving standard therapy.

Indication: Relief of inflammatory manifestations of corticosteroid-responsive dermatoses.

Indication: Relief of inflammatory & pruritic manifestations of corticosteroid-responsive dermatoses (eg, psoriasis, e...

Indication: Acute & chronic rheumatic fever, RA, bronchial asthma, myositis, dermatitis.

Indication: Prophylaxis of acute organ rejection in patients receiving allogeneic renal, cardiac & hepatic transplants...

Indication: Psoriasis, recalcitrant eczemas, lichen planus, discoid lupus erythematosus & other condition which do not...

Indication: Moderate to severe forms of scalp psoriasis in ≥18 yr.

1  /  7
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 3 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 5 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.